Skip to content
10-Q

Quarterly Report

CUBIST PHARMACEUTICALS INC

0000912183-14-000006

← back to feed
Filed
Nov 7, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 3, 2014 76.3M sh
Shares Diluted Q3 2014 · Sep 30, 2014 86M sh
Shares Diluted Q3 2014 · Sep 30, 2014 85.9M sh
Shares Diluted Q3 2014 · Sep 30, 2013 67.84M sh
Shares Diluted Q3 2014 · Sep 30, 2013 66.12M sh
Capex Q3 2014 · Sep 30, 2014 $21.07M
Capex Q3 2014 · Sep 30, 2013 $11.69M
Cash And Equivalents Q3 2014 · Sep 30, 2014 $233.69M
Cash And Equivalents Q3 2014 · Dec 31, 2013 $91.06M
Cash And Equivalents Q3 2014 · Sep 30, 2013 $538.5M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $104.04M
Stockholders Equity Q3 2014 · Sep 30, 2014 $1.54B
Stockholders Equity Q3 2014 · Dec 31, 2013 $1.39B
Current Liabilities Q3 2014 · Sep 30, 2014 $274.89M
Current Liabilities Q3 2014 · Dec 31, 2013 $310.83M
Total Liabilities Q3 2014 · Sep 30, 2014 $1.64B
Total Liabilities Q3 2014 · Dec 31, 2013 $1.75B
Current Assets Q3 2014 · Sep 30, 2014 $972.37M
Current Assets Q3 2014 · Dec 31, 2013 $870.17M
Total Assets Q3 2014 · Sep 30, 2014 $3.18B
Total Assets Q3 2014 · Dec 31, 2013 $3.15B
Eps Diluted Q3 2014 · Sep 30, 2014 $0.29
Eps Diluted Q3 2014 · Sep 30, 2014 $0.90
Eps Diluted Q3 2014 · Sep 30, 2013 −$0.50
Eps Diluted Q3 2014 · Sep 30, 2013 −$0.19
Eps Basic Q3 2014 · Sep 30, 2014 $0.30
Eps Basic Q3 2014 · Sep 30, 2014 $0.94
Eps Basic Q3 2014 · Sep 30, 2013 −$0.50
Eps Basic Q3 2014 · Sep 30, 2013 −$0.19
Sga Expense Q3 2014 · Sep 30, 2014 $77.79M
Sga Expense Q3 2014 · Sep 30, 2014 $227.51M
Sga Expense restated Q3 2014 · Sep 30, 2013 $73.86M
Sga Expense restated Q3 2014 · Sep 30, 2013 $171.95M
Rd Expense Q3 2014 · Sep 30, 2014 $66.03M
Rd Expense Q3 2014 · Sep 30, 2014 $291.5M
Rd Expense Q3 2014 · Sep 30, 2013 $123.42M
Rd Expense Q3 2014 · Sep 30, 2013 $352.82M
Net Income Q3 2014 · Sep 30, 2014 $22.83M
Net Income Q3 2014 · Sep 30, 2014 $71.09M
Net Income Q3 2014 · Sep 30, 2013 −$33.9M
Net Income Q3 2014 · Sep 30, 2013 −$12.57M
Operating Income Q3 2014 · Sep 30, 2014 $67.81M
Operating Income Q3 2014 · Sep 30, 2014 $138.29M
Operating Income Q3 2014 · Sep 30, 2013 $4.06M
Operating Income Q3 2014 · Sep 30, 2013 $41.92M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $94.96M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $257.11M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $60.99M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $179.71M
Revenue Q3 2014 · Sep 30, 2014 $309.16M
Revenue Q3 2014 · Sep 30, 2014 $864.79M
Revenue Q3 2014 · Sep 30, 2013 $265.99M
Revenue Q3 2014 · Sep 30, 2013 $754.7M